Advertisement
Advertisement
November 10, 2022
Viz.ai’s Viz Aneurysm System Studied for Detecting Unruptured Cerebral Aneurysms
November 10, 2022—Viz.ai, a developer of artificial intelligence (AI)–powered disease detection and intelligent care coordination, announced highlights of new data demonstrating the benefit of the use of the company’s Viz Aneurysm at a large hospital system. The study will be presented at the Society of Vascular and Interventional Neuroradiology’s 2022 SVIN annual meeting held November 16-19 in Los Angeles, California.
According to the company, Viz Aneurysm automatically analyzes CTAs for suspected cerebral aneurysm and facilitates referrals. This new real-world data impacts care coordination for patients with suspected unruptured cerebral aneurysms, stated Viz.ai.
Investigators used Viz Aneurysm to screen approximately 1,200 CTAs for stroke evaluation at eight stroke centers across Texas. A total of 85% of the aneurysms detected by Viz Aneurysm had not been previously referred for follow-up. The median size of all aneurysms was 5 mm, and 45% were > 7 mm.
Sunil A. Sheth, MD, a vascular and interventional neurologist and Assistant Professor of Neurology at UTHealth McGovern Medical School in Houston, Texas, is the study’s primary investigator.
"In our study, Viz Aneurysm not only demonstrated the value of automated detection but also the significant importance of facilitating referrals to the appropriate specialist, so fewer aneurysms get missed, helping more people,” commented Dr. Sheth in the company’s press release.
Jayme Strauss, RN, Chief Clinical Officer of Viz.ai, added, “This real-world clinical evidence validates the impact of Viz Aneurysm in a large study. These data demonstrate the importance of workflow efficiency that Viz can bring to unruptured cerebral aneurysm, assuring the patient is referred to the right provider, possibly impacting rupture and mortality rates.”
More information on the study results and Viz Aneurysm will be presented during a Viz.ai webinar with Dr. Sheth and Jayme Strauss at 6:00 pm ET on November 29.
Advertisement
Advertisement